Additionally, Dr. Einat Brill Almon, the Company's Senior Vice President of Product Development, will be presenting at the 3rd International Conference on Plant-Based Vaccines & Antibodies in Italy.
In a release, the company noted event details:
The conference schedule is as follows:
8th Annual Needham Life Sciences Conference: Healthcare Today & Tomorrow Corporate Presentation, June 10 at 2:30 PM ET New York Palace Hotel, New York, NY
A webcast of this presentation will be available at protalix.com
3rd International Conference on Plant-Based Vaccines & Antibodies Presentation entitled, "'Novel enzyme replacement therapy for Gaucher disease: Ongoing Phase III trials with recombinant human glucocerebrosidase expressed in plant cells," June 15 at 2 PM CET University of Verona, Verona, Italy
8th National Life Science and Technology Week ISLI-Biomed Israel 2009
Corporate Presentation, June 16 at the BioPharma Session, 4:20-6:20 PM IDT David Intercontinental Hotel, Tel-Aviv, Israel
Protalix is a biopharmaceutical company.
((Comments on this story may be sent to health@closeupmedia.com))

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index